Intellia Therapeutics

Youtube Subscribe

Open: 26.5 Close: 27.18 Change: 0.68

Are you looking for information about Intellia Therapeutics Company Inc? We programmed an AI to summarize it for you.

Are looking for the most relevant information about Intellia Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Intellia Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Intellia Therapeutics are: Intellia, Therapeutics, NTLA, Feb, PM, Phase, Inc, and the most common words in the summary are: therapeutic, intellia, stock, company, news, inc, best, . One of the sentences in the summary was: Cathie Woods ARK funds just added another 98,000 shares of NTLA.. …

Concept Map

Semantic Network

Stock Summary

Intellia Therapeutics Inc. (NTLA) Director Muna Bhanji sold 1,867 shares of the company in a transaction on Thursday, July 6th. Director Munani Bhanj now holds 12.

Today's Summary

Intellia Therapeutics (NTLA) posted Phase 1 study results of its NTLA-2002 for hereditary angioedema ( HAE ) in the New England Journal of Medicine. Cathie Woods ARK funds just added another 98,000 shares of NTLA.

Today's News

Intellia Therapeutics, Inc. (NTLA) NASDAQ: NTLA · IEX Real-Time Price · USD Add to Watchlist 27.18 +0.30 (1.12%) At close: Feb 22, 2024, 4:00 PM 27.23 + 0.05 (0.18%) After-hours: Feb. 22, 24.00 PM EST - NTLA ($76) - - UnoWe view firmware ent015av Intellia Therapeutics to Present Updated Data from Ongoing Phase 1 Study of NTLA-2001 for the Treatment of Transthyretin (ATTR) Amyloidosis in November. Intellia Therapeutics (NTLA) posted Phase 1 study results of its NTLA-2002 for hereditary angioedema ( HAE ) in the New England Journal of Medicine. Cathie Woods ARK funds just added another 98,000 shares of NTLA for $2.6 million. Intellya Therapeutic stock price move in real-time ahead here. Intellia Therapeutics (NASDAQ:NTLA) Trading Down 9.2% Zolmax.com provides the latest financial news as it breaks.

Stock Profile

" Intellia Therapeutics Inc. (NTLA) Director Muna Bhanji sold 1,867 shares of the company in a transaction on Thursday, July 6th. Cyndeo Wealth Partners LLC acquired a new position in Intellya Therapeutic, Inc. in Stock. Intellia Therapeutics is anticipated to post earnings of ($4.05) per share for the year. This forecast comes amidst a consensus estimate of $5.33 per share. Director Muna Bhanji now holds 12,526 shares in the company valued at $492,271. Wall Street analysts think its a good time to buy Intellia Therapeutics stock. Out of 16 sell side analysts who give forecasts on NTLA, the consensus analyst rating is a Strong Buy. NTLA does not generate passive income. Cambridge, MA, is hiring associate director, clinical data management in cambridge, massachusetts, united states. Sandia Investment Management LP acquired a new position in shares of Intellia Therapeutics in the fourth quarter valued at approximately $35,000. CWM LLC boosted its holdings in shares by 2,072.7% in the first quarter. Raymond James & Associates owns 0.06% of Intellia Therapeutics worth $1,972,000 at the end of the most recent quarter. Director Muna Bhanji sold 1,867 shares of the businesss stock in a transaction on Thursday, July 6th."

Keywords

The game is changing. There is a new strategy to evaluate Intellia Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Intellia Therapeutics are: Intellia, Therapeutics, NTLA, Feb, PM, Phase, Inc, and the most common words in the summary are: therapeutic, intellia, stock, company, news, inc, best, . One of the sentences in the summary was: Cathie Woods ARK funds just added another 98,000 shares of NTLA.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #intellia #stock #company #news #inc #best.

Read more →

Youtube Subscribe

---